the protease inhibitor aprotinin ( trasylol ) , given as a continuous intravenous infusion 1000 kallikrein inhibitor units ( k.i.u . ) kg-1h-1 together with a bolus of 40,000 k.i.u . kg-1 , significantly inhibited the severity and incidence of the initial endotoxin response ( increase in right atrial pressure and systemic hypotension ) , perhaps suggesting the direct or indirect involvement of kinins .
C0003641
aprotinin
C0592198
trasylol